Dr. Agarwal on PFS2 Data From the TITAN Trial in mCSPC
Neeraj Agarwal, MD, director of the Genitourinary Oncology Program, Oncology Division, professor of medicine, physician, and investigator at Huntsman Cancer Institute, discusses data from a posthoc analysis of the phase III TITAN trial in patients with metastatic castration-sensitive prostate cancer (mCSPC).
Website: https://www.onclive.com
Twitter: / onclive
Facebook: / onclive
LinkedIn: / onclive
Watch video Dr. Agarwal on PFS2 Data From the TITAN Trial in mCSPC online without registration, duration hours minute second in high quality. This video was added by user OncLive 08 April 2020, don't forget to share it with your friends and acquaintances, it has been viewed on our site 119 once and liked it 0 people.